GlassScriptPhysician profile
Jamie Engeldrum
NPI 1902444300
$1,338.13
in general payments reported to CMS, 2019-2025
19 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $162 · 2022: $215 · 2023: $308 · 2024: $281 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $961.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $182.96 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Teva Pharmaceuticals USA, INC. | $172.31 | 2021-2025 | Austedo Xr, Austedo Xr |
| Abbvie INC. | $127.89 | 2023-2025 | |
| Novo Nordisk INC | $109.40 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $104.92 | 2021-2023 | |
| Amgen INC. | $93.96 | 2023-2025 | Repatha, Otezla, Otezla |
| Exact Sciences Corporation | $88.32 | 2023-2025 | Cologuard Collection Kit |
| Vanda Pharmaceuticals INC. | $76.03 | 2025 | Fanapt |
| Lilly USA, LLC | $71.65 | 2022-2025 | Mounjaro |
| Sanofi Pasteur INC. | $66.93 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $60.57 | 2021-2022 | |
| Genentech USA, INC. | $47.76 | 2021-2022 | |
| Lundbeck LLC | $32.57 | 2022-2025 | Rexulti |
| Biohaven Pharmaceuticals, INC. | $21.65 | 2021 | |
| Astellas Pharma US INC | $21.16 | 2024 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.44 | 2025 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $15.41 | 2022 | |
| Kyowa Kirin, INC. | $14.00 | 2024 | Crysvita |
| Glaxosmithkline, LLC. | $13.20 | 2023 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Engeldrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.